clarithromycin has been researched along with tigecycline in 31 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 8 (25.81) | 29.6817 |
2010's | 20 (64.52) | 24.3611 |
2020's | 3 (9.68) | 2.80 |
Authors | Studies |
---|---|
Appelbaum, PC; Clark, CL; Ednie, LM; Kosowska-Shick, K | 1 |
Baudry, PJ; DeCorby, M; Hoban, DJ; Johnson, J; Karlowsky, JA; Lagacé-Wiens, P; Laing, N; McCracken, M; Mulvey, MR; Nichol, KA; Tailor, F; Vashisht, R; Walkty, A; Weshnoweski, B; Wierzbowski, A; Zhanel, GG | 1 |
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Esteban, J; Fernández-Martínez, AI; Fernández-Roblas, R; Gadea, I; García-Almeida, D; Martín-de-Hijas, NZ | 1 |
Gikas, A; Psaroulaki, A; Spyridaki, I; Tselentis, Y; Vranakis, I | 1 |
Chen, H; Chen, M; Liu, Y; Ma, Y; Nichols, WW; Sun, W; Wang, H; Zhang, J; Zhao, C | 1 |
Hakanen, AJ; Huovinen, P; Kotilainen, P; Lehtopolku, M; Nakari, UM; Siitonen, A | 1 |
Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Petrini, B | 1 |
Bono, BR; Qamar, F; Zuckerman, JM | 1 |
Hsueh, PR; Lee, PI; Yang, JC | 1 |
Bricaire, F; Caumes, E; Monsel, G; Roujeau, JC; Schneider, P; Veziris, N | 1 |
Borisevich, SV; Iakovlev, EA; Lukin, EP | 1 |
Chen, JH; Hu, ST; Huang, CC; Huang, CW; Huang, WC; Lee, YC; Shen, GH | 1 |
Carter, ER; Iwanaga, K | 1 |
Campos Gutierrez, S; Díaz Cuevas, Z; Lecuona Fernández, M; Rodríguez-Lozano, B | 1 |
Bajwa, G; Hirose, H; Karbowski, P; Miessau, J; Unai, S | 1 |
Alves, SH; Bizzi, K; Ferreiro, L; Jesus, FP; Loreto, ÉS; Ludwig, A; Pilotto, MB; Santurio, JM; Tondolo, JS; Zanette, RA | 1 |
Alves, SH; Loreto, ES; Pilotto, MB; Santurio, JM; Tondolo, JS | 1 |
Alves, SH; Azevedo, MI; Driemeier, D; Ferreiro, L; França, RT; Jesus, FP; Lopes, ST; Loreto, ÉS; Ludwig, A; Pilotto, MB; Ribeiro, TC; Santurio, JM; Souza, SO; Tondolo, JS | 1 |
Bakker-Woudenberg, IA; Bax, HI; de Steenwinkel, JE; Ten Kate, MT; Verbon, A | 1 |
Bouziane, F; Cambau, E; Chau, F; Crockett, F; Mougari, F; Nessar, R; Raskine, L; Sapriel, G; Veziris, N | 1 |
Chang, CT; Doerr, KM; Whipps, CM | 1 |
Chen, NY; Chiu, CH; Chung, WH; Kuo, AJ; Lai, HC; Lee, MC; Liu, TP; Lu, JJ; Sun, PL; Wang, LH; Wu, TL; Wu, TS; Yang, CH; Yang, JH | 1 |
Arthur, M; Compain, F; Dorchène, D; Dubée, V; Gaillard, JL; Herrmann, JL; Heym, B; Soroka, D | 1 |
Burian, J; Pryjma, M; Thompson, CJ | 1 |
Baba, S; Fukuoka, K; Horikoshi, Y; Kamada, K; Kanemaru, A; Kikuchi, K; Myojin, S; Okamoto, Y; Suzuki, H; Yoshida, A | 1 |
Gonzales Zamora, JA; Villar Astete, A | 1 |
Bonet-Rossinyol, Q; Fernández-Pittol, M; Gonzalez-Martin, J; López-Gavín, A; Portell-Buj, E; Roman, A; Tudó, G | 1 |
Ammerman, NC; Bax, HI; de Steenwinkel, JEM; de Vogel, CP; Mudde, SE; Schildkraut, JA; van Ingen, J | 1 |
5 review(s) available for clarithromycin and tigecycline
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
Topics: Administration, Oral; Amikacin; Anti-Bacterial Agents; Azithromycin; Clarithromycin; Cystic Fibrosis; Drug Resistance, Bacterial; Drug Therapy, Combination; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Respiratory Tract Infections; Skin; Soft Tissue Infections; Species Specificity; Surgical Wound Infection; Tigecycline; Tuberculosis, Cutaneous; Wounds and Injuries | 2006 |
Macrolides, ketolides, and glycylcyclines: azithromycin, clarithromycin, telithromycin, tigecycline.
Topics: Anti-Bacterial Agents; Azithromycin; Bacterial Infections; Clarithromycin; Humans; Ketolides; Macrolides; Minocycline; Tetracyclines; Tigecycline | 2009 |
[Present stage of chemotherapy and chemoprophylaxis of rickettsiosis and Q fever].
Topics: Anti-Bacterial Agents; Chemoprevention; Chloramphenicol; Clarithromycin; Doxycycline; Female; Fluoroquinolones; Humans; Macrolides; Minocycline; Pregnancy; Pregnancy Complications, Infectious; Q Fever; Rickettsia Infections; Tigecycline; Trimethoprim, Sulfamethoxazole Drug Combination | 2011 |
Sternal wound infection caused by Mycobacterium chelonae.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Therapy, Combination; Heart Atria; Heart Neoplasms; Humans; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Myxoma; Pectoralis Muscles; Sternotomy; Sternum; Surgical Flaps; Surgical Wound Infection; Thoracic Surgical Procedures; Tigecycline; Treatment Outcome | 2013 |
26 other study(ies) available for clarithromycin and tigecycline
Article | Year |
---|---|
Capability of 11 antipneumococcal antibiotics to select for resistance by multistep and single-step methodologies.
Topics: Anti-Bacterial Agents; Aza Compounds; Azithromycin; Clarithromycin; Clavulanic Acid; Clindamycin; Drug Resistance, Bacterial; Fluoroquinolones; Gemifloxacin; Imipenem; Ketolides; Levofloxacin; Microbial Sensitivity Tests; Moxifloxacin; Naphthyridines; Ofloxacin; Quinolines; Streptococcus pneumoniae | 2007 |
Antimicrobial-resistant pathogens in intensive care units in Canada: results of the Canadian National Intensive Care Unit (CAN-ICU) study, 2005-2006.
Topics: Adolescent; Adult; Aged; Anti-Bacterial Agents; beta-Lactamases; Canada; Drug Resistance, Bacterial; Female; Gram-Negative Bacteria; Gram-Negative Bacterial Infections; Gram-Positive Bacteria; Gram-Positive Bacterial Infections; Humans; Intensive Care Units; Male; Microbial Sensitivity Tests; Middle Aged; Population Surveillance | 2008 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
In vitro activities of tigecycline and 10 other antimicrobials against nonpigmented rapidly growing mycobacteria.
Topics: Anti-Bacterial Agents; Drug Resistance, Bacterial; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Mycobacterium; Mycobacterium Infections; Pigmentation; Species Specificity; Tigecycline | 2008 |
Bacteriostatic and bactericidal activities of tigecycline against Coxiella burnetii and comparison with those of six other antibiotics.
Topics: Animals; Anti-Bacterial Agents; Chlorocebus aethiops; Coxiella burnetii; Humans; Microbial Sensitivity Tests; Minocycline; Q Fever; Tigecycline; Vero Cells | 2009 |
Prevalence and characterization of heterogeneous vancomycin-intermediate Staphylococcus aureus isolates from 14 cities in China.
Topics: Anti-Bacterial Agents; China; Cities; Drug Resistance, Multiple, Bacterial; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin; Vancomycin Resistance | 2009 |
Antimicrobial susceptibilities of multidrug-resistant Campylobacter jejuni and C. coli strains: in vitro activities of 20 antimicrobial agents.
Topics: Anti-Bacterial Agents; Campylobacter coli; Campylobacter Infections; Campylobacter jejuni; Carbapenems; Drug Resistance, Multiple, Bacterial; Erythromycin; Feces; Finland; Humans; Macrolides; Microbial Sensitivity Tests; Minocycline; Tigecycline | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
In vitro activity of nemonoxacin, tigecycline, and other antimicrobial agents against Helicobacter pylori isolates in Taiwan, 1998-2007.
Topics: Amino Acid Substitution; Amoxicillin; Anti-Bacterial Agents; Aza Compounds; Ciprofloxacin; Clarithromycin; DNA Gyrase; Drug Resistance, Multiple, Bacterial; Fluoroquinolones; Gemifloxacin; Helicobacter Infections; Helicobacter pylori; Humans; Levofloxacin; Metronidazole; Microbial Sensitivity Tests; Minocycline; Moxifloxacin; Mutation; Naphthyridines; Ofloxacin; Quinolines; Quinolones; Sequence Analysis, Protein; Taiwan; Tetracyclines; Tigecycline | 2010 |
Successful treatment of nodular lymphangitis due to Mycobacterium chelonae in two immunosuppressed patients.
Topics: Administration, Oral; Aged, 80 and over; Anti-Bacterial Agents; Clarithromycin; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Immunocompromised Host; Injections, Intravenous; Lymphangitis; Male; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Tigecycline; Tobramycin; Treatment Outcome | 2011 |
Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Drug Synergism; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium Infections, Nontuberculous; Nontuberculous Mycobacteria; Taiwan; Tigecycline | 2013 |
Mycobacterium abscessus complex lung infection in a toddler with a tracheostomy.
Topics: Amikacin; Anti-Bacterial Agents; Bronchopulmonary Dysplasia; Child, Preschool; Clarithromycin; Female; Humans; Laryngostenosis; Minocycline; Mycobacterium Infections, Nontuberculous; Tigecycline; Tomography, X-Ray Computed; Tracheostomy; Tuberculosis, Pulmonary | 2014 |
[Nodular skin lesions in a patient with rheumatoid arthritis under therapy with anti-tumor necrosis factor-α].
Topics: Antibodies, Monoclonal; Arthritis, Rheumatoid; Azathioprine; Biological Products; Clarithromycin; Drug Substitution; Female; Humans; Immunocompromised Host; Immunosuppressive Agents; Infliximab; Middle Aged; Minocycline; Mycobacterium chelonae; Mycobacterium Infections, Nontuberculous; Prednisone; Skin Diseases, Bacterial; Tigecycline; Tumor Necrosis Factor-alpha | 2014 |
In vitro synergism observed with azithromycin, clarithromycin, minocycline, or tigecycline in association with antifungal agents against Pythium insidiosum.
Topics: Animals; Antifungal Agents; Azithromycin; Clarithromycin; Drug Combinations; Drug Synergism; Humans; In Vitro Techniques; Microbial Sensitivity Tests; Minocycline; Pythiosis; Pythium; Tigecycline | 2014 |
New insights into the in vitro susceptibility of Pythium insidiosum.
Topics: Acetamides; Anti-Bacterial Agents; Antifungal Agents; Azithromycin; Clarithromycin; Doxycycline; Linezolid; Microbial Sensitivity Tests; Minocycline; Mupirocin; Oxazolidinones; Pythium; Tigecycline | 2014 |
In Vitro and In Vivo Antimicrobial Activities of Minocycline in Combination with Azithromycin, Clarithromycin, or Tigecycline against Pythium insidiosum.
Topics: Animals; Antifungal Agents; Azithromycin; Clarithromycin; Drug Administration Schedule; Drug Synergism; Drug Therapy, Combination; Microbial Sensitivity Tests; Minocycline; Multivariate Analysis; Pythiosis; Pythium; Rabbits; Skin; Tigecycline | 2016 |
Tigecycline Potentiates Clarithromycin Activity against Mycobacterium avium In Vitro.
Topics: Anti-Bacterial Agents; Clarithromycin; Dose-Response Relationship, Drug; Drug Combinations; Drug Resistance, Bacterial; Drug Synergism; Microbial Sensitivity Tests; Minocycline; Mycobacterium avium; Tigecycline; Time Factors | 2016 |
Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Ciprofloxacin; Clarithromycin; Imipenem; Linezolid; Microbial Sensitivity Tests; Minocycline; Mutation; Mycobacterium; Tigecycline | 2017 |
Antibiotic treatment of zebrafish mycobacteriosis: tolerance and efficacy of treatments with tigecycline and clarithromycin.
Topics: Animals; Anti-Bacterial Agents; Clarithromycin; Female; Fish Diseases; Male; Minocycline; Mycobacterium chelonae; Mycobacterium Infections; Tigecycline; Time Factors; Zebrafish | 2017 |
Antimicrobial resistance in Mycobacterium abscessus complex isolated from patients with skin and soft tissue infections at a tertiary teaching hospital in Taiwan.
Topics: Amikacin; Anti-Bacterial Agents; Bacterial Proteins; Clarithromycin; Drug Resistance, Bacterial; High-Throughput Nucleotide Sequencing; Hospitals, Teaching; Humans; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Skin; Skin Diseases, Bacterial; Soft Tissue Infections; Taiwan; Tertiary Care Centers; Tigecycline | 2017 |
In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Topics: Amikacin; Anti-Bacterial Agents; Ciprofloxacin; Clarithromycin; Drug Combinations; Drug Resistance, Multiple, Bacterial; Humans; Linezolid; Microbial Sensitivity Tests; Minocycline; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Oxazolidinones; Tetrazoles; Tigecycline | 2018 |
Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
Topics: Anti-Bacterial Agents; Clarithromycin; Drug Resistance, Multiple, Bacterial; Drug Synergism; Drug Therapy, Combination; High-Throughput Screening Assays; Humans; Microbial Sensitivity Tests; Microbial Viability; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Rifabutin; Small Molecule Libraries; Tigecycline | 2018 |
Chronic otitis media caused by Mycobacterium abscessus spp. massiliense treated with tigecycline in a 10-year-old child.
Topics: Amikacin; Anti-Bacterial Agents; Child; Chronic Disease; Clarithromycin; Humans; Male; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Otitis Media; Tigecycline; Tokyo | 2018 |
Topics: Abscess; Anti-Bacterial Agents; Clarithromycin; Debridement; Female; Finger Phalanges; Humans; Imipenem; Linezolid; Magnetic Resonance Imaging; Middle Aged; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Osteomyelitis; Tigecycline | 2020 |
Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
Topics: Amikacin; Anti-Bacterial Agents; Clarithromycin; Colony Count, Microbial; Drug Combinations; Humans; Imipenem; Microbial Sensitivity Tests; Mycobacterium abscessus; Mycobacterium Infections, Nontuberculous; Tigecycline | 2021 |
Unraveling antibiotic resistance mechanisms in Mycobacterium abscessus: the potential role of efflux pumps.
Topics: Amikacin; Anti-Bacterial Agents; Cefoxitin; Clarithromycin; Clofazimine; Drug Resistance, Multiple, Bacterial; Humans; Microbial Sensitivity Tests; Mycobacterium abscessus; Thioridazine; Tigecycline; Verapamil | 2022 |